Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DAWN

Day One Biopharmaceuticals (DAWN)

Day One Biopharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DAWN
DateTimeSourceHeadlineSymbolCompany
05/30/20247:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
05/28/20245:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
05/24/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
05/17/20245:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
05/17/20245:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
05/16/20245:34PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
05/16/20245:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
05/14/20245:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
05/06/20243:35PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DAWNDay One Biopharmaceuticals Inc
05/06/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
03/07/20243:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
02/28/20246:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
02/27/20243:27PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
02/20/20245:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
02/20/20245:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
02/16/20244:51PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
01/17/20247:25AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
01/09/20246:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
01/09/20246:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
01/08/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
01/04/20243:06PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DAWNDay One Biopharmaceuticals Inc
11/17/20235:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
11/17/20235:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
11/17/20236:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
11/16/20235:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
11/15/20233:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
11/06/20233:48PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DAWNDay One Biopharmaceuticals Inc
11/06/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
10/30/20239:54AMDow Jones NewsDay One Biopharmaceuticals Shares Rally on FDA Priority ReviewNASDAQ:DAWNDay One Biopharmaceuticals Inc
10/30/20237:58AMDow Jones NewsDay One Gets FDA Priority Review of Tovorafenib in Pediatric Brain TumorNASDAQ:DAWNDay One Biopharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:DAWN